Company / Financials
Co-Diagnostics, Inc. Financials
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$622.5K
FY2025 · -84.1% YoY
Net Income
-$46.9M
FY2025 · -24.6% YoY
Profit Margin
-7533.6%
FY2025 · net income / revenue
ROE
-227.3%
FY2025 · return on equity
Total Assets
$24.7M
FY2025
Total Debt
-
FY2025
Equity
$20.6M
FY2025
ROA
-189.5%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$622.5K-84.1% YoYNet Income HistoryProfit after all expenses and taxes-$46.9M-24.6% YoYGross Profit HistoryRevenue minus cost of goods sold$400.1K-86.3% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$222.4K-77.7% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$50.2M-25.2% YoYSG&A Expense HistorySelling, general, and administrative expenses$9.1M-43.9% YoYR&D Expense HistoryResearch and development spending$19.1M-8.8% YoYInterest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense-$1.6M-2916.9% YoYEPS (Basic) HistoryBasic earnings per share-$37.22-3001.7% YoY